Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial - Sulkowski, M S; Eron, J J; Wyles, D (Jama, 2015)
et al.